RCAD002 / IAVI R002
A phase 1 randomized, placebo-controlled clinical trial to test the safety and immunogenicity of an oral, replicating Ad26 vectored HIV-1 vaccine in healthy adults
We are looking for healthy men and women ages 18-50 years old for a clinical trial of an experimental HIV vaccine given in capsule form.
Note: it is impossible to get HIV infection from the study vaccine.
If you would like to be considered for participation, please complete the form at right.
We are available to discuss your concerns and answer your questions.